Literature DB >> 19086770

Narrowing in on compulsions: dopamine receptor functions.

Gregory T Collins1, James H Woods.   

Abstract

A series of experiments in rats explored the possibility that D3/D2 dopamine receptors are involved in behaviors that might be related to compulsion. A series of D3/D2 agonists and antagonists were shown to elicit yawning (D3-receptor mediated) and its inhibition (D2-receptor mediated). In rats with histories of cocaine exposure, D3-agonist-elicited yawning was enhanced, and quinpirole led to persistent operant responding only if conditioned stimuli associated with cocaine were presented for responding. Finally, a more selective D3 partial agonist was reported that had a novel profile of activity that could have relevance to the suppression of dopamine-related compulsions. (c) 2008 APA, all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19086770      PMCID: PMC3094917          DOI: 10.1037/a0014190

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  13 in total

1.  Drug and reinforcement history as determinants of the response-maintaining effects of quinpirole in the rat.

Authors:  Gregory T Collins; James H Woods
Journal:  J Pharmacol Exp Ther       Date:  2007-08-03       Impact factor: 4.030

2.  Compulsive-like effects of repeated administration of quinpirole on drinking behavior in rats.

Authors:  Davide Amato; Michele S Milella; Aldo Badiani; Paolo Nencini
Journal:  Behav Brain Res       Date:  2006-05-04       Impact factor: 3.332

Review 3.  Medication-related impulse control and repetitive behaviors in Parkinson disease.

Authors:  Valerie Voon; Susan H Fox
Journal:  Arch Neurol       Date:  2007-08

Review 4.  The D3 dopamine receptor: neurobiology and potential clinical relevance.

Authors:  B Levant
Journal:  Pharmacol Rev       Date:  1997-09       Impact factor: 25.468

5.  Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.

Authors:  Gregory T Collins; Jeffrey M Witkin; Amy H Newman; Kjell A Svensson; Peter Grundt; Jianjing Cao; James H Woods
Journal:  J Pharmacol Exp Ther       Date:  2005-04-15       Impact factor: 4.030

6.  Self-administration of the dopamine D3 agonist 7-OH-DPAT in rhesus monkeys is modified by prior cocaine exposure.

Authors:  M A Nader; R H Mach
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

7.  Design, synthesis, and evaluation of potent and selective ligands for the dopamine 3 (D3) receptor with a novel in vivo behavioral profile.

Authors:  Jianyong Chen; Gregory T Collins; Jian Zhang; Chao-Yie Yang; Beth Levant; James Woods; Shaomeng Wang
Journal:  J Med Chem       Date:  2008-09-12       Impact factor: 7.446

Review 8.  Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease.

Authors:  M F Piercey
Journal:  Clin Neuropharmacol       Date:  1998 May-Jun       Impact factor: 1.592

Review 9.  Sustained-release naltrexone: novel treatment for opioid dependence.

Authors:  Sandra D Comer; Maria A Sullivan; Gary K Hulse
Journal:  Expert Opin Investig Drugs       Date:  2007-08       Impact factor: 6.206

10.  Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A.

Authors:  Patricia Di Ciano; Rachel J Underwood; Jim J Hagan; Barry J Everitt
Journal:  Neuropsychopharmacology       Date:  2002-06-18       Impact factor: 7.853

View more
  1 in total

1.  Differential Roles for Dopamine D1-Like and D2-Like Receptors in Mediating the Reinforcing Effects of Cocaine: Convergent Evidence from Pharmacological and Genetic Studies.

Authors:  Takato Hiranita; Gregory T Collins
Journal:  J Alcohol Drug Depend       Date:  2015-07-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.